MeiraGTx Holdings (MGTX) Treasury Shares (2017 - 2026)
MeiraGTx Holdings' (MGTX) quarterly Treasury Shares came in at $6.2 million in Q4 2025, up 45.43% YoY from $4.3 million in Q4 2024, and little changed on a QoQ basis from $6.2 million in Q3 2025.
Analysis
MeiraGTx Holdings (MGTX) Treasury Shares (2017 - 2026) Analysis & Trends
MeiraGTx Holdings (MGTX) has 9 years of Treasury Shares data on file, last reported at $6.2 million in Q4 2025.
- Quarterly Treasury Shares rose 45.43% year-over-year to $6.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $6.2 million (up 45.43% YoY) and the FY2025 annual result came in at $6.2 million, up 45.43% from the prior year.
- Treasury Shares was little changed at $6.2 million in Q4 2025, from $6.2 million in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $6.3 million in Q2 2025 to a low of $1.4 million in Q3 2021.
- A 5-year average of $3.4 million and a median of $2.8 million in 2023 frame the typical range for Treasury Shares.
- Annual changes were most pronounced in 2024 — Treasury Shares soared 59.78% — and 2025, when it fell 17.22%.
- Tracing MGTX's Treasury Shares over 5 years: stood at $1.4 million in 2021, then surged by 54.24% to $2.2 million in 2022, then rose by 21.94% to $2.7 million in 2023, then soared by 59.78% to $4.3 million in 2024, then jumped by 45.43% to $6.2 million in 2025.
- The last three Treasury Shares figures came in at $6.2 million (Q4 2025), $6.2 million (Q3 2025), and $6.3 million (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 2.72 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | MeiraGTx Holdings | 1.27 Bn | 1.13 Bn | 315.67 Mn | 18.19 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 18.19 Mn |
| Jun 30, 2026 | 18.19 Mn |
| Dec 31, 2025 | 2.30 Mn |
| Dec 31, 2025 | 2.30 Mn |
| Mar 31, 2018 | 9.36 Mn |
| Mar 31, 2018 | 9.36 Mn |
| Dec 31, 2017 | 5.01 Mn |
| Dec 31, 2017 | 5.01 Mn |